A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment.
“We tested the antibody in various ways, including on tumour cells from myeloma patients that have been transplanted into mice. The tests showed that the antibody is able to destroy myeloma cells”, explains Markus Hansson, a researcher at Lund University in Sweden.
Using a ‘biological library’ of thousands of antibodies from the company BioInvent in Lund, the team singled out antibody BI-505, shown to have a powerful effect on the tumour cells in both cell studies and animal experiments. It has also been tested in an initial safety study on seriously ill patients, and a study of its treatment effects has just started.
“This study will include patients who have just been diagnosed and therefore still feel fairly well. We want to test the antibody treatment before the patients are treated with any other drugs”, says Markus Hansson.
Today there are a number of drugs to treat multiple myeloma, but no cure. None of the drugs are able to eradicate the disease, meaning cancer cells increase in number after a period of remission. Survival has been extended with new treatments, but less than half of all patients live longer than five years from diagnosis.
Myeloma occurs when a specific type of cell in the bone marrow is converted into tumour cells. Blood formation is disrupted and patients suffer from a lack of blood resulting in fatigue. The bones can be weakened with a risk of fractures and compacted vertebrae, and patients sometimes suffer kidney failure as a result of the disease.
Antibodies are a part of the immune system, fighting off foreign bodies. Antibody-based drugs are now used to treat certain inflammatory diseases and types of cancer.
The treatment study in Lund will involve 15 patients and is expected to be completed this year.
The Latest Bing News on:
Multiple myeloma
- His Cancer Journey Shows Health Dangers Firefighters Faceon May 10, 2024 at 6:10 am
For 14 years, David Perez fought fires in South Florida, thinking he was in peak physical shape. Then a routine physica ...
- Can Multiple Myeloma Be Cured Naturally? A Review By Doctorson May 10, 2024 at 5:39 am
Expert opinion from Ilya AleksandrovskiyM.D., MBA · 5 years of experience · USAThere are no specific diets that have been proved to help people with multiple myeloma. However, particular nutrition ...
- Kite and Arcellx prepare to launch Phase III multiple myeloma trialon May 10, 2024 at 1:21 am
Kite, a Gilead Company, and Arcellx have announced plans to commence a Phase III clinical trial of anitocabtagene autoleucel (anito-cel), for treating multiple myeloma. Anito-cel is a B-cell ...
- Buy Rating Affirmed for 2seventy bio on Strong Growth Prospects and Financial Stabilityon May 9, 2024 at 10:33 pm
Leerink Partners analyst Daina Graybosch has maintained their bullish stance on TSVT stock, giving a Buy rating on May 8. Daina Graybosch has ...
- Buy Rating for Arcellx Inc: Strategic Positioning and Promising Clinical Trials Fuel Positive Outlookon May 9, 2024 at 8:25 pm
William Blair analyst Sami Corwin has maintained their bullish stance on ACLX stock, giving a Buy rating on May 7. Sami Corwin has given his ...
- VA cited for more than yearlong delay on veterans benefits for Agent Orange exposureon May 9, 2024 at 2:32 pm
More than 10,500 benefits claims for leukemia, multiple myeloma and other diseases related to herbicide exposure were overlooked for more than a year by the Department of Veterans Affairs, according ...
- Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Programon May 9, 2024 at 1:05 pm
Kite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates on their partnered anitocabtagene autoleucel (anito-cel) multiple myeloma ...
- Immunomodulatory Drugs in Multiple Myelomaon May 8, 2024 at 5:00 pm
This review summarizes the mechanisms of action and clinical activity of IMiDs in MM. Multiple myeloma (MM) is a malignant plasma cell disorder accounting for approximately 10% of all hematologic ...
- Assessing Peripheral Neuropathy Role in Acupuncture for Managing Multiple Myelomaon May 8, 2024 at 1:04 am
The following is a summary of "Acupuncture in Multiple Myeloma Peripheral Neuropathy: A Systematic Review," published in the April 2024 issue of Pain by Lyu et al. Though a common complication of ...
- What Is The Imf Doing For The Prevention And Cure Of Multiple Myeloma? A Review By Doctorson May 7, 2024 at 2:28 pm
Expert opinion from Marcella Abunahman Pereira Specialization in Clinical Cardiology · 12 years of experience · Brazil The IMF (International Myeloma Foundation) is dedicated to improving the quality ...
The Latest Google Headlines on:
Multiple myeloma
[google_news title=”” keyword=”Multiple myeloma” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Cancer of the blood
- Sensation in legs could be red flag symptom of common cancer, according to doctoron May 10, 2024 at 6:13 am
Tests might include urine analysis, a PSA blood test - which can show elevated levels in both BPH and cancer - and sometimes checks on kidney function, reports Gloucestershire Live. Dr Porter ...
- Ask A Nutrition Professional: What Are The Health Benefits Of Having Red Wine?on May 10, 2024 at 5:02 am
Expert opinion from Cassia D Muller Bechelor in Nutrition · 2 years of experience · Brazil Wine contains resveratrol, a compound present mainly in the skins of purple grapes and which has antioxidant ...
- A blood test to help detect lung cancer? New test offered at OSF Healthcare part of trend in medicineon May 10, 2024 at 3:00 am
Julie Harris had never been tested for lung cancer. A low-dose CT scan, the only recommended screening for adults at risk of developing lung cancer, was not something she’d ever found time to do. But ...
- Standard blood cancer treatment reveals positive results in those over 80, study findson May 10, 2024 at 1:11 am
The standard treatment for acute myeloid leukemia (AML) is safe and effective for adults over 80, a study published Thursday in Blood Neoplasia finds. The treatment can extend survival for about 25% ...
- Social Support Is Key During BiTE Therapy for Blood Cancerson May 9, 2024 at 12:30 pm
An oncology nurse discusses what patients should know before BiTE therapy, and what they can do if they do not have a social support system.
- Older adults with aggressive blood cancer are responsive to treatment and show prolonged survivalon May 9, 2024 at 7:00 am
Standard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over 80, according to a study published in Blood Neoplasia. For roughly a quarter of patients, this ...
- The Future of Antibody-Drug Conjugates in Lung Cancer Treatmenton May 9, 2024 at 6:52 am
Drs Jacob Sands and Benjamin P. Levy discuss antibody-drug conjugates in lung cancer treatment, including differences in efficacy, toxicity profiles, and what the future holds.
- Supercharging immune cells to battle blood cancer: Breakthrough in cancer immunotherapyon May 8, 2024 at 5:00 pm
A new study reveals a groundbreaking approach to immunotherapy, demonstrating that blocking the interaction between the CD300A receptor and phosphatidylserine (PS) significantly enhances the ability ...
- Researchers develop a nanoparticle that can penetrate the blood-brain barrieron May 6, 2024 at 12:00 pm
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed a nanoparticle that can penetrate the blood-brain barrier. Their goal is to ...
- Two-punch treatment delivers blood cancer knockout: Study shows drug combo eradicates cancer cells in lab-based testson May 1, 2024 at 6:47 am
A novel combination of two cancer drugs has shown great potential as a future treatment for patients with acute myeloid leukemia (AML), one of the most common types of blood cancers. A new study by ...
The Latest Google Headlines on:
Cancer of the blood
[google_news title=”” keyword=”cancer of the blood” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]